Skip Navigation



Europace Advance Access published online on October 29, 2009
Europace, doi:10.1093/europace/eup317
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
12/1/17    most recent
eup317v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Andrikopoulos, G.
Right arrow Articles by Vardas, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrikopoulos, G.
Right arrow Articles by Vardas, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

REVIEW

Monitoring capabilities of cardiac rhythm management devices

George Andrikopoulos1, Stylianos Tzeis2, George Theodorakis1 and Panos Vardas3,*

1 Cardiology Department, 'Henry Dunant' Hospital, Athens, Greece; 2 Deutsches Herzzentrum und Medizinische Klinik, Faculty of Medicine, Technischen Universität München, Munich, Germany; 3 Cardiology Department, Heraklion University Hospital, PO Box 1352, 71110 Heraklion, Crete, Greece

Since the advent of the first generation pacemakers, solely providing rate support, we have witnessed a technological outburst in the type and complexity of implantable devices. The introduction of implantable cardioverter defibrillators and later of cardiac resynchronization therapy devices enriched our therapeutic arsenal for the management of patients with heart failure and/or high risk of sudden cardiac death. In addition, during the last decade, newer generation cardiac rhythm management devices (CRMs) have been capable to provide a continuously expanding pool of diagnostic information derived by novel monitoring capabilities. Although at present the clinical role of this information is undervalued, it is evident that the clinical exploitation of data derived by CRMs may transform the standards of care for our patients by providing timely applied individualized diagnosis and treatment. In this context, even in the absence of solid data supporting the use of this information in everyday clinical practice, improving our familiarity with currently available monitoring algorithms is a perquisite for the electrophysiologist who keeps in pace with the rapidly evolving technologies of CRMs and is prepared for their future role on clinical practice.

Key Words: Implantable devices, Monitoring, Algorithms

* Corresponding author. Tel: +30 2810 392422, Fax: +30 2810 542055, Email: cardio{at}med.uoc.gr

Manuscript submitted 24 December 2008. Accepted after revision 21 September 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.